GAM
BSX icon

Groupama Asset Management’s Boston Scientific BSX Stock Holding History

Groupama Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.1M Buy
1,571,750
+196,489
+14% +$10.7M 0.86% 33
2026
Q1 		$86.3M Buy
1,375,261
+8,356
+0.6% +$668K 1.26% 24
2025
Q4 		$130M Buy
1,366,905
+34,424
+3% +$3.37M 1.91% 15
2025
Q3 		$130M Sell
1,332,481
-77,295
-5% -$8M 1.91% 13
2025
Q2 		$150M Buy
1,409,776
+108,866
+8% +$11M 2.48% 10
2025
Q1 		$129M Buy
1,300,910
+156,979
+14% +$15.8M 2.58% 8
2024
Q4 		$103M Buy
1,143,931
+191,887
+20% +$16.9M 2.1% 8
2024
Q3 		$64.1M Buy
952,044
+88,081
+10% +$6.94M 1.66% 14
2024
Q2 		$66.5M Buy
863,963
+107,729
+14% +$7.89M 0.9% 26
2024
Q1 		$60.2M Buy
756,234
+305,356
+68% +$19.6M 1.1% 24
2023
Q4 		$26.1M Buy
+450,878
New +$24.1M 0.68% 35

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Groupama Asset Management's BSX Position: Q2 2026 in Review

Groupama Asset Management increased its Boston Scientific (BSX) stake by 14% in Q2 2026, buying an estimated $10.7M and bringing the position to 1,571,750 shares worth $68.1M. The position accounts for 0.86% of the portfolio, ranked #33.

Groupama Asset Management first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $150M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Groupama Asset Management held 1,571,750 shares of Boston Scientific worth $68.1M as of Q2 2026.
  • Groupama Asset Management bought 196,489 Boston Scientific shares in Q2 2026, an estimated $10.7M.
  • Boston Scientific made up 0.86% of Groupama Asset Management's portfolio in Q2 2026, its #33 holding.
  • Groupama Asset Management first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Groupama Asset Management's Boston Scientific position peaked at $150M in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.